Presentation TCT 2012 Retrograde Application of Autologous BM Cells: Phase 2 Study Results Presenter: Amit Patel October 22, 2012
Presentation TCT 2012 New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on “When to Treat” Presenter: Jeffrey Popma October 22, 2012
Presentation TCT 2012 “Direct” Aortic Access is Easier, Safer, and Should be the Preferred Access Alternative! Presenter: Michael Reardon October 22, 2012
Presentation TCT 2012 “Nuggets” on Patient Selection After > 1,000 TAVR Cases (Performed and/or Proctored): Self-Expanding TAVR Presenter: Ganesh Manoharan October 22, 2012
Presentation TCT 2012 Pioneer and Interventional Perspectives Presenter: Alain Cribier October 22, 2012
Presentation TCT 2012 TAVR Use Patterns on the European Continent: Growth, Penetration, and Reimbursement Presenter: Nicolo Piazza October 22, 2012
Presentation TCT 2012 Debate II. Should Renal Artery Stenting Only Be Done Using FFR and IVUS? Pro! Presenter: Mehdi Shishehbor October 22, 2012
Presentation TCT 2012 CTO Case Volumes and the Learning Curve: Insights from the European CTO Registry Presenter: Carlo Di Mario October 22, 2012
Presentation TCT 2012 Ixmyelocel-T for CHF: Results of Catheter-based Study Presenter: Timothy Henry October 22, 2012
Presentation TCT 2012 Are COURAGE and FAME Irrelevant (or Less Relevant) with Current Generation DES? Presenter: Dean Kereiakes October 22, 2012